| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 741 | 2021 |
| Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2 H Greulich, B Kaplan, P Mertins, TH Chen, KE Tanaka, CH Yun, X Zhang, ... Proceedings of the National Academy of Sciences 109 (36), 14476-14481, 2012 | 325 | 2012 |
| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 236 | 2022 |
| Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma RG Liao, J Jung, J Tchaicha, MD Wilkerson, A Sivachenko, ... Cancer research 73 (16), 5195-5205, 2013 | 203 | 2013 |
| BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2 MS Cline, RG Liao, MT Parsons, B Paten, F Alquaddoomi, A Antoniou, ... PLoS genetics 14 (12), e1007752, 2018 | 200 | 2018 |
| Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors L Tan, J Wang, J Tanizaki, Z Huang, AR Aref, M Rusan, SJ Zhu, Y Zhang, ... Proceedings of the National Academy of Sciences 111 (45), E4869-E4877, 2014 | 194 | 2014 |
| Facilitating a culture of responsible and effective sharing of cancer genome data LL Siu, M Lawler, D Haussler, BM Knoppers, J Lewin, DJ Vis, RG Liao, ... Nature medicine 22 (5), 464-471, 2016 | 100 | 2016 |
| Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells J Wang, O Mikse, RG Liao, Y Li, L Tan, PA Janne, NS Gray, KK Wong, ... Oncogene 34 (17), 2167-2177, 2015 | 84 | 2015 |
| A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes JM Mercader, RG Liao, AD Bell, Z Dymek, K Estrada, T Tukiainen, ... Diabetes 66 (11), 2903-2914, 2017 | 62 | 2017 |
| Targeted therapy for squamous cell lung cancer RG Liao, H Watanabe, M Meyerson, PS Hammerman Lung cancer management 1 (4), 293-300, 2012 | 57 | 2012 |
| RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade B Bockorny, M Rusan, W Chen, RG Liao, Y Li, F Piccioni, J Wang, L Tan, ... Molecular cancer therapeutics 17 (7), 1526-1539, 2018 | 55 | 2018 |
| Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC JH Tchaicha, EA Akbay, A Altabef, OR Mikse, E Kikuchi, K Rhee, RG Liao, ... Cancer research 74 (17), 4676-4684, 2014 | 43 | 2014 |
| SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues M D’Antonio, JP Nguyen, TD Arthur, H Matsui, BM Neale, M Daly, ... Cell reports 37 (7), 2021 | 29 | 2021 |
| Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape DJ Vis, J Lewin, RG Liao, M Mao, F Andre, RL Ward, F Calvo, BT Teh, ... Annals of Oncology 28 (5), 1145-1151, 2017 | 20 | 2017 |
| BRCA1/2 variant data-sharing practices JM Bollinger, A Sanka, L Dolman, RG Liao, R Cook-Deegan The Journal of Law, Medicine & Ethics 47 (1), 88-96, 2019 | 11 | 2019 |
| Determining barriers to effective data sharing in cancer genomic sequencing initiatives: A Global Alliance for Genomics and Health (GA4GH) survey. JH Lewin, DJ Vis, EE Voest, R Liao, PM Nederlof, BA Conley, DB Solit, ... Journal of Clinical Oncology 34 (15_suppl), 11502-11502, 2016 | 3 | 2016 |
| Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a pan-FGFR inhibitor in a mouse model of NSCLC EA Akbay, JH Tchaicha, A Altabef, OR Mikse, E Kikuchi, K Rhee, R Liao, ... Cancer Research 74 (19_Supplement), 4851-4851, 2014 | 1 | 2014 |
| COVID-19 Host Genetics Initiative. A first update on mapping the human genetic architecture of COVID-19 GA Pathak, R Polimanti, J Karjalainen, M Daly, A Ganna, MJ Daly, ... University of Leicester, 2022 | | 2022 |
| Large variations in clinical and ethical aspects of genomic sequencing initiatives: A Global Alliance for Genomics and Health (GA4GH) survey J Lewin, DJ Vis, M Lawler, R Liao, M Mao, BT Teh, W Sellers, R Ward, ... Cancer Research 76 (14_Supplement), 1832-1832, 2016 | | 2016 |
| Heterogeneity of mutation calling and annotation: a survey of cancer next-generation sequencing initiatives by the Global Alliance for Genomics and Health (GA4GH) DJ Vis, J Lewin, L Siu, R Liao, JC Zenklusen, F Calvo, E Szepessy, ... Cancer Research 76 (14_Supplement), 5287-5287, 2016 | | 2016 |
